Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Emergent Technologies, Inc.
Receptor Logic, Inc. Launches New Website
May 27th, 2009
Biopharmaceutical company Receptor Logic, Inc. announced the unveiling of its newly redesigned website, www.receptorlogic.com. Expanded sales and partnership activities in 2008 necessitated an improved website providing clear navigation to the three business areas comprising the Receptor Logic model: therapeutic antibodies, assay services and research reagents. Receptor Logic has developed a new antibody platform, known as T-Cell Receptor mimic (TCRm™) antibodies, that enables new therapeutic monoclonal antibody products and assists cancer drug developers in characterizing the activities of their investigational active immunotherapies drugs, including cancer vaccines....
Source: Vaccine Weekly (2009-05-27)
|
